FindTrial
Sign In

Survey on Convalescent Plasma (CVP) for COVID-19

Survey-based study on Convalescent Plasma (CVP) for COVID-19 - ConPlaS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026331
Enrollment
2200
Registered
2020-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Not applicable: Not applicable Control Intervention1: Not applicable: Not applicable

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Not applicable

Exclusion criteria

Exclusion criteria: Anyone aged below 18 years.

Design outcomes

Primary

MeasureTime frame
1. To explore the knowledge, attitude, and practices of medical professionals regarding the convalescent plasma as a promising therapy for the current COVID-19 pandemic. 2. To explore the knowledge, attitude of public in community regarding the convalescent plasma as a promising therapy for the current COVID-19 pandemic.Timepoint: 3 months—

Secondary

MeasureTime frame
1. To explore the knowledge-based difference between the public and healthcare workers regarding the CVP for COVID-19 2. To assess the difference in attitude of donor against non-donors regarding CVP donation. 3. To explore the knowledge-based difference of healthcare workers of different cadres regarding the CVP donations for the current COVID-19 pandemic.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDiptiranjan Rout

National Cancer Institute (AIIMS), Jhajjar

drdiptiranjanrout@gmail.com01251274758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026